←
Chris Carswell9,341 posts
Chris Carswell avatar

Chris Carswell

@PECjournal

Editor in Chief PharmacoEconomics. Past President ISPOR NZ Chapter, ex pharmacist, run and play the piano. UK expat in New Zealand. All views are my own

◷ Joined January 2010▧ 194 Photos and videos
Chris Carswell avatar
Chris Carswell@PECjournal·13 Sep 2024

Seems to me the QALY is so entrenched in many countries it would take a huge effort to move away from it

This tweet is unavailable

Stephanie Harvard avatar
⟳ Chris Carswell retweeted
Stephanie Harvard@newsvava·19 Jan 2024

Second, this solo editorial in Pharmacoeconomics, called "Making Models Fit for Purpose: the Importance of Ensuring Stakeholder Involvement". Also available free right here! rdcu.be/dwnP1

Mike Paulden avatar
⟳ Chris Carswell retweeted
Mike Paulden@mikepaulden·8 Dec 2023

My 'Framework for the Fair Pricing of Medicines' has just been published as a Leading Article by Pharmacoeconomics. This framework proposes a number of advancements to existing approaches for specifying a 'cost-effectiveness threshold' for new medicines. link.springer.com/article/10…

Hareth Al-Janabi avatar
⟳ Chris Carswell retweeted
Hareth Al-Janabi@HajBrum·5 Sep 2023

Including carer outcomes in economic evaluation is important & can reveal unrecognised challenges in HTA decisions. One of these is where patient & carer QALYs point in different directions - work led by @davidjohnmott and colleagues @OHENews @HEU_UoB link.springer.com/article/10…

dr cate bailey avatar
⟳ Chris Carswell retweeted
dr cate bailey@catebailey1·2 May 2023

Thread update on the QUOKKA project led by the brilliant @nancydevlin1 - huge output from this multi-university project on measuring and valuing child QoL

1/10 Time flies! @QUOKKA_Research is now in its 3rd and final year. Here's a thread with a quick overview of where we're at and what we'll be doing this year!

Chris Carswell avatar
Chris Carswell@PECjournal·22 Mar 2023

Terrible grammar is a key sign!

Academic publishing scams are getting very good, having had a paper published yesterday this came through soon after. If it wasn't for the terrible grammar I would have clicked on the link. Be careful out there! I was so pleased I'd been nominated!

Post attachment
Zanfina Ademi avatar
⟳ Chris Carswell retweeted
Zanfina Ademi@ZANFINA·22 Mar 2023

Congratulations @dinaabushanab10 on this massive work on projecting the health and economic burden of CVD among people with type 2 diabetes @claremarquina @JedidiahMorton @PECjournal link.springer.com/article/10…

James O'Mahony 🇺🇦🇵🇸☮️ avatar
⟳ Chris Carswell retweeted
James O'Mahony 🇺🇦🇵🇸☮️@jamesfomahony·2 Mar 2023

At @ipha's conference. The Minister just mentioned Ireland's €45,000/QALY threshold and that there is an existing pathway for orphan drugs to exceed it. Interesting confirmation of the threshold and that it doesn't always apply.

Post attachment
NICE avatar
⟳ Chris Carswell retweeted
NICE@NICEComms·13 Feb 2023

Antimicrobial resistance or #AMR, as known in short, is a global health crisis. Find out how we're applying a new 'Netflix' style payment model to boost the antimicrobial pipeline, which has already assessed 2 new antimicrobial drugs⬇️ link.springer.com/article/10…

Seb Hinde avatar
⟳ Chris Carswell retweeted
Seb Hinde@sebh2005·3 Feb 2023

Long shot but are there any health economist out there would would review a journal paper for me? My last PhD by publication paper has been stuck in one journal for 5 months with no reviewers, I think it is now down to me to find one!